Olema Pharmaceuticals's total assets for Q2 2025 were $382.00M, a decrease of -6.75% from the previous quarter. OLMA total liabilities were $36.77M for the fiscal quarter, a 40.40% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.